Topical pain relief:
Indications for: LIDODERM
Postherpetic neuralgia (PHN).
Adult Dosage:
Apply to intact skin, covering most painful area. To adjust dose, cut patches before removing release liner. Remove if irritation or burning occurs; do not reapply until irritation subsides. May apply up to 3 patches at once for up to 12hrs of a 24-hour period. Hepatic impairment or debilitated: use smaller treatment areas.
Children Dosage:
Not established.
LIDODERM Warnings/Precautions:
Risk of methemoglobinemia (esp. in G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants <6 months of age, concurrent exposure to oxidizing agents or metabolites); monitor. Accidental exposure to children and pets. Do not apply to broken or inflamed skin. Avoid eyes, mucous membranes, longer duration of application, and application of more than 3 patches. Avoid direct external heat sources (eg, heating pads, electric blankets). History of drug sensitivities. Hepatic disease. Small patients. Pregnancy (Cat.B). Labor & delivery. Nursing mothers.
LIDODERM Classification:
Topical anesthetic.
LIDODERM Interactions:
Increased risk of methemoglobinemia when concurrently exposed to nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, others. Toxicity may be potentiated by Class I antiarrhythmics (eg, tocainide, mexiletine). Additive effects with other products containing local anesthetics.
Adverse Reactions:
Local effects (eg, erythema, edema), allergic reactions (eg, urticaria, angioedema, bronchospasm).
Generic Drug Availability:
YES
How Supplied:
Patches (10cm x 14cm)—30
